Trademark: 97761230
Word
ATHERGENBIO
Status Date
Tuesday, July 23, 2024
Filing Date
Thursday, January 19, 2023
Published for Opposition
Tuesday, May 28, 2024
42 Vaccine research and development; Research and development of vaccines and medicines; Research, development, engineering and testing services in the fields of immunopharmaceuticals and vaccines
Jan 23, 2023
New Application Entered
Feb 9, 2023
New Application Office Supplied Data Entered
May 15, 2023
Attorney/Dom.Rep.Revoked And/Or Appointed
May 15, 2023
Teas Change Of Correspondence Received
Oct 17, 2023
Assigned To Examiner
Oct 24, 2023
Non-Final Action Written
May 15, 2023
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
May 15, 2023
Teas Withdrawal Of Attorney Received-Firm Retains
Oct 24, 2023
Non-Final Action E-Mailed
Oct 24, 2023
Notification Of Non-Final Action E-Mailed
Jan 24, 2024
Application Extension Granted/Receipt Provided
Jan 24, 2024
Application Extension To Response Period - Received
Jan 26, 2024
Teas Withdrawal Of Attorney Received-Firm Retains
Jan 26, 2024
Teas Change Of Correspondence Received
Apr 22, 2024
Teas/Email Correspondence Entered
Apr 22, 2024
Teas Response To Office Action Received
Apr 24, 2024
Approved For Pub - Principal Register
May 8, 2024
Notification Of Notice Of Publication E-Mailed
May 28, 2024
Published For Opposition
May 28, 2024
Official Gazette Publication Confirmation E-Mailed
Jul 23, 2024
Noa E-Mailed - Sou Required From Applicant
Jan 26, 2024
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Jan 26, 2024
Attorney/Dom.Rep.Revoked And/Or Appointed
Apr 22, 2024
Correspondence Received In Law Office
Trademark Alertz updated from USPTO on 2030-01-24